Aspen Neuroscience, Inc. [ASPE] - IPO
Aspen Neuroscience, Inc. is offering 9,375,000 shares of common stock at an initial public offering price of $15.00 per share, raising total gross proceeds of $140,625,000 before underwriting discounts and commissions.
Why this matters
Aspen Neuroscience, Inc. is a pharmaceutical company focused on developing personalized cell therapies for neurological disorders, leveraging its expertise in stem cell biology and regenerative medicine. The company has launched an initial public offering, offering 9,375,000 shares of common stock at $15.00 per share, aiming to raise $140,625,000 in gross proceeds before underwriting discounts and commissions. This move to go public may be part of a strategic effort to secure capital for advancing its clinical programs and expanding its research capabilities.